
The HR Analytics & Reporting Specialist delivers accurate, timely and actionable HR reporting and analytics to support data-driven decision-making and workforce planning. The role ensures HR data quality, develops and maintains dashboards and reports, and drives process automation and continuous improvement. Working closely with global and local P&O teams, Finance, ESG and other stakeholders, the specialist provides insights into workforce trends and supports reporting, planning and compliance requirements.
Working with Valneva means being part of a global biotech company with a clear vision to make a meaningful impact in the world. At Valneva, you can expect a dynamic and innovative work environment characterized by an open, appreciative company culture and exciting, impactful assignments. Enjoy the benefits of flat hierarchies, an international atmosphere, and regular company events that foster collaboration and connection.
Additionally, we offer:
Minimum Annual Salary: EUR 52.000,- gross per year. The actual salary offered will be determined based on the candidate’s qualifications, professional experience, and skills, with a willingness to overpay the applicable minimum salary.
Join us and shape the future of biotechnology!

Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines.
Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 700 employees.